Azd-1222/dexamethasoneLack of efficacy and hyperglycaemia following off label use: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1906卷 / 1期

关键词：

D O I：

10.1007/s40278-022-14990-0

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：100 / 100

相关论文

共 50 条

[21] AZD-1222/immune-globulin/tocilizumabVein thrombosis, lack of efficacy and off-label-use.
Reactions Weekly, 2024, 2005 (1) : 150 - 150
[22] DexamethasoneLack of efficacy following an off-label treatment: case report
Reactions Weekly, 2022, 1929 (1) : 244 - 244
[23] DexamethasoneLack of efficacy following an off-label treatment: case report
Reactions Weekly, 2022, 1924 (1) : 189 - 189
[24] AZD-1222/fibrinogen/immune-globulinVaccine-induced thrombotic thrombocytopenia, intracerebral haemorrhage following off label use and lack of efficacy during preganancy: case report
Reactions Weekly, 2021, 1886 (1) : 84 - 84
[25] Alteplase/dexamethasoneLack of efficacy and off-label use: case report
Reactions Weekly, 2022, 1935 (1) : 29 - 29
[26] DexamethasoneLack of efficacy following off label use: 2 case reports
Reactions Weekly, 2023, 1960 (1) : 162 - 162
[27] DexamethasoneLack-of efficacy with off-label use: case report
Reactions Weekly, 2022, 1913 (1) : 179 - 179
[28] Baricitinib/dexamethasoneLack of efficacy following off label use
Reactions Weekly, 2024, 2004 (1) : 84 - 84
[29] Azithromycin/dexamethasoneLack of efficacy following off label use
Reactions Weekly, 2024, 2006 (1) : 123 - 123
[30] Ampicillin/sulbactam/dexamethasoneLack of efficacy and off label use: case report
Reactions Weekly, 2022, 1915 (1) : 35 - 35

← 1 2 3 4 5 →